India Glycols Limited (INDIAGLYCO)
Updates
Apportionment of cost of acquisition for shares post-demerger communicated
- Scheme sanctioned by NCLT on 17-Jul-2026, effective 1-Sep-2026
- Resulting Company 1 shares allotted at 1:3 ratio; Resulting Company 2 at 1:1 ratio
- Cost of acquisition apportioned: India Glycols 31.77%, Ennature Bio Pharma 20.61%, IGL Spirits 47.62%
- Guidance for shareholders on tax cost basis allocation
- Shareholders advised to consult tax advisors for specific implications
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 INDIAGLYCO — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add INDIAGLYCO to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on India Glycols Limited
Important.
The summary above is generated automatically from India Glycols Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.